Yahoo! JAPAN

2024/5/13 -mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease.

13時間前 -Moderna shares were down another 7.8% Wednesday morning after falling 8% Tuesday, crimping what had been the stock's best month in years.

2024/4/24 -Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and ...

2023/12/17 -A Dose-finding Study to Evaluate mRNA-3210 in Participants with Phenylketonuria. This study is: Recruiting. Moderna TX ID. mRNA-3210-P101.

2024/4/24 -Moderna's objective was to achieve 100% adoption and proficiency of generative AI by all its people with access to digital solutions in six months. “We believe ...

2024/1/18 -Moderna, Inc is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

2024/2/22 -Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55. Reports full-year revenues of $6.8 billion, ...

2024/5/2 -In the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company's ...

2024/5/2 -Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07) Prepares for launches of RSV vaccine and ...

6日前 -Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious ...